Mk 458

(4aR-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride; [4aR,(+)]-3,4,4aß,5,6,10ba-Hexahydro-4a-propyl-2H-naphtho[1,2-b]-1,4-oxazine-9-ol; 3,4,4aß,5,6,10ba-Hexahydro-4a-propyl-2H-naphtho[1,2-b]-1,4-oxazine-9-ol; R-(+)-PHNO; R(+)-PHNO; MK 458; (+)-PHNO Hydrochloride; (+)-Propyl-9-hydroxynaphthoxazine Hydrochloride;(+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth(1,2-b)-1,4-oxazin-9-ol hydrochloride; 2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)-; L 647,339; L-647,339; MK-458; Naxagolide HCl; Naxagolide hydrochloride; UNII-E5KFJ9796W; Systematic Name 2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)-; Registry Numbers CAS Registry Number 99705-65-4;FDA UNII E5KFJ9796W;System Generated Number 0099705654; Molecular Formulas ?Molecular Formula C15-H21-N-O2.Cl-H;Molecular Formula Fragments C15-H21-N-O2; Cl-H; COMPONENT;